CIDARA THERAPEUTICS, INC. Shareholders' Equity
CIDARA THERAPEUTICS, INC. had Shareholders' Equity of $422.39 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-11-06
- 2025-09-30: Stockholders' Equity Attributable to Parent $422.39M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $501.17M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $141.68M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $163.31M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-09-30 | $422.39M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $501.17M 10-Q · filed 2025-11-06 | |
| 2025-03-31 | $141.68M 10-Q · filed 2025-11-06 | |
| 2024-12-31 | $163.31M 10-Q · filed 2025-11-06 | |
| 2024-09-30 | $115.63M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $130.94M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | -$17.78M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | -$8.21M 10-Q · filed 2025-11-06 | |
| 2023-09-30 | -$5.89M 10-Q · filed 2024-11-07 | $8.04M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.42M 10-Q · filed 2024-11-07 | $15.41M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $15.11M 10-Q · filed 2024-11-07 | $26.84M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$14.44M 10-K · filed 2025-03-06 | -$2.90M 10-K · filed 2023-03-23 |
| 2022-09-30 | -$2.25M 10-K · filed 2024-04-22 | $9.07M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$18.54M 10-K · filed 2024-04-22 | -$7.96M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$3.71M 10-K · filed 2024-04-22 | $4.96M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $13.10M 10-K · filed 2024-04-22 | $21.57M 10-K · filed 2022-03-07 |
| 2021-09-30 | -$1.16M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $15.79M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $1.89M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $10.71M 10-K · filed 2023-03-23 | |
| 2020-09-30 | $29.55M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $41.35M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $53.75M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $37.84M 10-K · filed 2023-03-23 | |
| 2019-09-30 | $48.96M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $31.78M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $43.86M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $59.14M 10-K · filed 2022-03-07 | |
| 2018-09-30 | $69.93M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $82.14M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $50.92M 10-Q · filed 2019-11-08 | $50.92M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $59.74M 10-K · filed 2021-02-25 | |
| 2017-09-30 | $50.57M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $61.26M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $75.99M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $88.18M 10-K · filed 2020-03-04 | |
| 2016-09-30 | $73.92M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $84.81M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $95.08M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $103.91M 10-K · filed 2019-02-28 | |
| 2015-09-30 | $112.63M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $120.86M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | -$17.53M 10-Q · filed 2015-05-21 | |
| 2014-12-31 | -$11.45M 10-K · filed 2018-02-27 | |
| 2013-12-31 | -$1.40M 10-K · filed 2017-03-15 | |
| 2012-12-31 | -$65.00K 10-K · filed 2016-03-18 |